Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Scharf

Showing results (371-380 of 410) with videos related to

Pageof 41
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2009
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot studyChristoph Sucker, Christine Kurschat, Firuseh Farokhzad, et al.
Communications Biology|December 6, 2025
Insights into the structure and initial host attachment of the flagellotropic bacteriophage 7-7-1W E M Noteborn, R Ouyang, T Hoeksma, et al.
Thrombosis Research|August 8, 2002
Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitorsArtur-Aron Weber, Dan Meila, Collin Jacobs, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2009
The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathiesChristoph Sucker, Christine Kurschat, Gerd R Hetzel, et al.
Pharmacogenetics|October 3, 2002
No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitorsArtur-Aron Weber, Collin Jacobs, Dan Meila, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
[Prenatal substitution therapy in fetal alloimmune thrombocytopenia]G Giers, J Hoch, R Bald, et al.
Hamostaseologie|May 12, 2021
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Prenatal Diagnosis|June 1, 1996
Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpuraG Giers, J Hoch, H Bauer, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1996
[Fetal weight-adjusted intrauterine IgG therapy in neonatal alloimmune thrombocytopenia]G Giers, J Hoch, R Bald, et al.
Hamostaseologie|April 6, 2021
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Pageof 41

Showing results (371-380 of 410) with videos related to

Sort By:
Pageof 41
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2009
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot studyChristoph Sucker, Christine Kurschat, Firuseh Farokhzad, et al.
Communications Biology|December 6, 2025
Insights into the structure and initial host attachment of the flagellotropic bacteriophage 7-7-1W E M Noteborn, R Ouyang, T Hoeksma, et al.
Thrombosis Research|August 8, 2002
Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitorsArtur-Aron Weber, Dan Meila, Collin Jacobs, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2009
The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathiesChristoph Sucker, Christine Kurschat, Gerd R Hetzel, et al.
Pharmacogenetics|October 3, 2002
No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitorsArtur-Aron Weber, Collin Jacobs, Dan Meila, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
[Prenatal substitution therapy in fetal alloimmune thrombocytopenia]G Giers, J Hoch, R Bald, et al.
Hamostaseologie|May 12, 2021
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Prenatal Diagnosis|June 1, 1996
Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpuraG Giers, J Hoch, H Bauer, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1996
[Fetal weight-adjusted intrauterine IgG therapy in neonatal alloimmune thrombocytopenia]G Giers, J Hoch, R Bald, et al.
Hamostaseologie|April 6, 2021
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Pageof 41